Concepedia
Statistics
Publications
18
Citations
2.3K
H-Index
16
Active since
1999
Affiliations
Portola Pharmaceuticals (United States)(Current)
Millennium Engineering and Integration (United States)
Francis DeGuzman is an author at Portola Pharmaceuticals (United States) specializing in medicine, hemostasis, and pharmacology.
Publications per year
1999–2018
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa
Genmin Lu, Francis DeGuzman, Stanley J. Hollenbach et al. · Nature Medicine · 2013 · 697 citations
Medicine, Hematology, Pharmacology +16
P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries
Patrick André, Suzanne M. Delaney, Thomas J. LaRocca et al. · Journal of Clinical Investigation · 2003 · 348 citations · Full text
Medicine, Molecular Biology, Pharmacology +17
Integrin cytoplasmic tyrosine motif is required for outside-in αIIbβ3 signalling and platelet function
Debbie A. Law, Francis DeGuzman, Patrick W. Heiser et al. · Nature · 1999 · 321 citations
Life Sciences, Cell Biology, Molecular Biology +16
A thrombin receptor function for platelet glycoprotein Ib–IX unmasked by cleavage of glycoprotein V
Vanitha Ramakrishnan, Francis DeGuzman, Ming Bao et al. · Proceedings of the National Academy of Sciences · 2001 · 170 citations
Medicine, Biochemistry, Molecular Biology +16
PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model
Michael P. Reilly, Uma Sinha, Pierrette André et al. · Blood · 2010 · 133 citations · Full text
Medicine, Hematology, Molecular Biology +15
1–5 of 18